Leal Therapeutics Inks $30 Million Series A Extension
· vcnewsdaily.com
WORCESTER, MA, Leal Therapeutics, Inc. (Leal), a clinical-stage biopharmaceutical company, announced a second close of $30 million of its Series A financing.
Leal Therapeutics Inks $30 Million Series A Extension Back to Home
WORCESTER, MA, Leal Therapeutics, Inc. (Leal), a clinical-stage biopharmaceutical company, a...